Strategy Consulting
Optimize value for client organizations, products,
and portfolios across all stages of company
and product lifecycles
Corporate Strategy and Business Development
Support internal strategic planning and business development activities, and engagement / communications with key external stakeholders
Strategic Planning
Support informed internal decision-making around development and commercial strategy for individual products and portfolios
Investor and Pharma Engagement
Characterize competitive positioning and commercial opportunity to strengthen the value story for investors and pharma partners
Due Diligence and BD Support
Conduct robust commercial evaluation of external business development opportunities
Product and Portfolio Strategy
Develop strategies to optimize commercial performance of products and portfolios, and ensure readiness for evolving global market dynamics
Market Planning and Commercialization
Country assessment, strategy development, and tactical planning to deliver successful product launch and early commercialization across global markets
Competitive Readiness
Assess risks and opportunities of shifting competitive dynamics and ensure competitive readiness across potential market scenarios
Growth Planning
Conduct in-depth source of business and growth driver trade-off analyses and develop plans for optimizing commercial performance
Foundational Five
We utilize our Foundational Five toolkit of strategic and market assessment deliverables to support streamlined execution of critical strategic planning activities.
Competitive Landscape Assessment
Identify, understand, and map competitors
Indication Prioritization / Development Strategy
Assess development options to optimize program/portfolio potential
Strategic Positioning and Messaging
Define differentiators and external messaging priorities
Opportunity Assessment and Forecasting
Quantify opportunity and identify key value-determining assumptions
Strategic Roadmap
Chart the path forward: activities, milestones, timelines
Analyzing Key Product & Market Attributes
We leverage rigorous research and leading databases to characterize markets and asset value propositions
Patient Dynamics
Epidemiology, total treatable patients, diagnostic paradigm, patient journey
Market Dynamics
Treatment paradigm, current / forecasted market size, launch strategy
Unmet Needs
Clinical and/or economic unmet needs based on current standard of care
Scientific Viability
Perspectives on scientific rationale, precedent of scientific / clinical research
Physician Perspectives
Disease landscape, unmet needs, pricing potential, TPP perspectives
Payer Perspectives
Potential pricing, market access considerations, patient cost-sensitivity, gross-to-net